美银美林:下调广发证券(1776.HK)目标价至9.35港元 评级“中性”
美银美林发表报告指,广发证券(01776.HK)上半年纯利按年升45%至41亿元人民币,而次季纯利则按季跌58%,差过同业;至于上半年收益在交易量反弹下录按年升57%。

该行认为,广发证券上半年业绩与同业表现一致,但该行持续关注其潜在减值拨备的情况,最近中证监将其评级由AAA降至BBB,以反映其香港子公司录得外汇交易亏损。该行相信,广发证券今年不需要作出拨备,但是在有更好的可见性和解决方案之前,上述因素可能会影响公司及其股价。
美银美林称,上调广发证券今年盈利预测16%,惟降2020至2021年盈测14%至19%,因此目标价相应由11.6港元降至9.35港元,重申“中性”评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.